These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10765547)

  • 1. [Specific immune response to vaccination with an inactivated flue vaccine depending on prevaccine status and age of the person vaccinated].
    Stepanova LA; Linde A; Naĭkhin AN; Bichurina MA; Paramonova MS
    Vopr Virusol; 2000; 45(2):26-9. PubMed ID: 10765547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune response of elderly persons depending on the number of annual seasonal immunizations of live and inactivated influenza vaccines].
    Naĭkhin AN; Rudenko LG; Arden N; Katz J; Grigor'eva EP; Donina SA; Lesheva IuA; Rekstin AR; Cox N
    Vopr Virusol; 1998; 43(3):130-4. PubMed ID: 9702813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
    Yim K; Miles B; Zinsou R; Prince G; Boukhvalova M
    Vaccine; 2012 Feb; 30(7):1291-6. PubMed ID: 22210139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine--Assessing the immunogenicity and safety in an open label, uncontrolled study.
    Roggelin L; Vinnemeier CD; Meyer S; Witte K; Marx L; Theeß W; Burchard GD; Rolling T; Cramer JP
    Hum Vaccin Immunother; 2015; 11(10):2370-5. PubMed ID: 26114800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time.
    Künzel W; Glathe H; Engelmann H; Van Hoecke C
    Vaccine; 1996 Aug; 14(12):1108-10. PubMed ID: 8911005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
    Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
    Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine.
    Kojimahara N; Maeda A; Kase T; Yamaguchi N
    Vaccine; 2006 Aug; 24(33-34):5966-9. PubMed ID: 16777274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity].
    Slepushkin AN; Rudenko LG; Kendal AP; Monto AS; Beliaev AL; Burtseva EI; Grigor'eva EP; Obrosova-Serova NP; Ivanova VT; Bragina VE
    Vopr Virusol; 1994; 39(3):129-31. PubMed ID: 8091754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination.
    Bonduelle O; Yahia N; Siberil S; Benhabiles N; Carrat F; Krivine A; Rozenberg F; Dimitrov J; Kaveri SV; Curjol A; Tindel M; Louet M; Desert F; Launay O; Loulergue P; Badre G; Katlama C; Bricaire F; Samri A; Rousset D; van der Werf S; Jauréguiberry S; Combadiere B
    J Immunol; 2013 Jul; 191(2):623-31. PubMed ID: 23776176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.
    de Bruijn IA; Remarque EJ; Jol-van der Zijde CM; van Tol MJ; Westendorp RG; Knook DL
    J Infect Dis; 1999 Jan; 179(1):31-6. PubMed ID: 9841819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial Protection Induced by 2011-2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People.
    Camilloni B; Basileo M; Menculini G; Tozzi P; Iorio AM
    Adv Exp Med Biol; 2016; 897():45-53. PubMed ID: 26577530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.
    Sasaki S; Jaimes MC; Holmes TH; Dekker CL; Mahmood K; Kemble GW; Arvin AM; Greenberg HB
    J Virol; 2007 Jan; 81(1):215-28. PubMed ID: 17050593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific antibody response after influenza immunization in systemic lupus erythematosus.
    Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D
    J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the immune response in children multiply inoculated with an inactivated influenza vaccine].
    Rudenko LG; Vasil'eva RI; Smirnova LA; Doroshenko EM
    Vopr Virusol; 1988; 33(4):407-11. PubMed ID: 3195142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory immunoglobulin A antibody response is conserved in aged mice following oral immunization with influenza virus vaccine.
    Chen KS; Quinnan GV
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3291-6. PubMed ID: 2607339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.